First, aberrant promoter methylation of IGFBP‐3 gene, which silences its expression, is detected in human gastric cancer, colorectal cancer, breast cancer, and malignant mesothelioma cancer.20 This evidence concerns the gene IGFBP3 and breast carcinoma.